Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.

Bocci F, Tripathi SC, Vilchez Mercedes SA, George JT, Casabar JP, Wong PK, Hanash SM, Levine H, Onuchic JN, Jolly MK.

Integr Biol (Camb). 2019 Jun 1;11(6):251-263. doi: 10.1093/intbio/zyz021.

2.

Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer.

Jolly MK, Preca BT, Tripathi SC, Jia D, George JT, Hanash SM, Brabletz T, Stemmler MP, Maurer J, Levine H.

APL Bioeng. 2018 Aug 22;2(3):031908. doi: 10.1063/1.5024874. eCollection 2018 Sep.

3.

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.

Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM.

Nat Commun. 2019 Jan 16;10(1):254. doi: 10.1038/s41467-018-08109-6.

4.

Testing the gene expression classification of the EMT spectrum.

Jia D, George JT, Tripathi SC, Kundnani DL, Lu M, Hanash SM, Onuchic JN, Jolly MK, Levine H.

Phys Biol. 2019 Jan 18;16(2):025002. doi: 10.1088/1478-3975/aaf8d4.

PMID:
30557866
5.

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.

Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H.

Pharmacol Ther. 2019 Feb;194:161-184. doi: 10.1016/j.pharmthera.2018.09.007. Epub 2018 Sep 28. Review.

PMID:
30268772
6.

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.

Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, Somlo G, Jandial R, Ann D, Hanash S, Jove R, Yu H.

Cell Metab. 2018 Jun 5;27(6):1357. doi: 10.1016/j.cmet.2018.04.018. No abstract available.

7.

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.

Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, Somlo G, Jandial R, Ann D, Hanash S, Jove R, Yu H.

Cell Metab. 2018 Jan 9;27(1):136-150.e5. doi: 10.1016/j.cmet.2017.11.001. Epub 2017 Dec 14. Erratum in: Cell Metab. 2018 Jun 5;27(6):1357.

8.

Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.

Bocci F, Jolly MK, Tripathi SC, Aguilar M, Hanash SM, Levine H, Onuchic JN.

J R Soc Interface. 2017 Nov;14(136). pii: 20170512. doi: 10.1098/rsif.2017.0512.

9.

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.

Mbofung RM, McKenzie JA, Malu S, Zhang M, Peng W, Liu C, Kuiatse I, Tieu T, Williams L, Devi S, Ashkin E, Xu C, Huang L, Zhang M, Talukder AH, Tripathi SC, Khong H, Satani N, Muller FL, Roszik J, Heffernan T, Allison JP, Lizee G, Hanash SM, Proia D, Amaria R, Davis RE, Hwu P.

Nat Commun. 2017 Sep 6;8(1):451. doi: 10.1038/s41467-017-00449-z.

10.

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.

Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM.

Cancer Res. 2017 Aug 15;77(16):4414-4425. doi: 10.1158/0008-5472.CAN-16-2874. Epub 2017 Jun 23.

11.

Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?

Jolly MK, Tripathi SC, Somarelli JA, Hanash SM, Levine H.

Mol Oncol. 2017 Jul;11(7):739-754. doi: 10.1002/1878-0261.12084. Epub 2017 Jun 19. Review.

12.

Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.

Kerros C, Tripathi SC, Zha D, Mehrens JM, Sergeeva A, Philips AV, Qiao N, Peters HL, Katayama H, Sukhumalchandra P, Ruisaard KE, Perakis AA, St John LS, Lu S, Mittendorf EA, Clise-Dwyer K, Herrmann AC, Alatrash G, Toniatti C, Hanash SM, Ma Q, Molldrem JJ.

J Biol Chem. 2017 Jun 16;292(24):10295-10305. doi: 10.1074/jbc.M116.773051. Epub 2017 May 3.

13.

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.

Çeliktas M, Tanaka I, Tripathi SC, Fahrmann JF, Aguilar-Bonavides C, Villalobos P, Delgado O, Dhillon D, Dennison JB, Ostrin EJ, Wang H, Behrens C, Do KA, Gazdar AF, Hanash SM, Taguchi A.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-9. doi: 10.1093/jnci/djw231.

14.

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.

Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, Heymach JV, Swisher SG, Bernatchez C, Alatrash G, Hanash S, Molldrem JJ.

Cancer Immunol Res. 2017 Apr;5(4):319-329. doi: 10.1158/2326-6066.CIR-16-0141. Epub 2017 Mar 2.

15.

Distinguishing mechanisms underlying EMT tristability.

Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H.

Cancer Converg. 2017;1(1):2. doi: 10.1186/s41236-017-0005-8. Epub 2017 Nov 1.

16.

Stability of the hybrid epithelial/mesenchymal phenotype.

Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H.

Oncotarget. 2016 May 10;7(19):27067-84. doi: 10.18632/oncotarget.8166.

17.

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.

Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, Hanash SM, Ostrin EJ.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1555-64. doi: 10.1073/pnas.1521812113. Epub 2016 Feb 29.

18.

Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil.

Pandey A, Vishnoi K, Mahata S, Tripathi SC, Misra SP, Misra V, Mehrotra R, Dwivedi M, Bharti AC.

Nutr Cancer. 2015;67(8):1293-304. doi: 10.1080/01635581.2015.1085581. Epub 2015 Oct 22.

PMID:
26492225
19.

Involvement of phosphoesterases in tributyl phosphate degradation in Sphingobium sp. strain RSMS.

Rangu SS, Basu B, Muralidharan B, Tripathi SC, Apte SK.

Appl Microbiol Biotechnol. 2016 Jan;100(1):461-8. doi: 10.1007/s00253-015-6979-1. Epub 2015 Sep 23.

PMID:
26399413
20.

MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.

Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, Kucherlapati R, Boutin AT, Wang YA, DePinho RA, Feng Z, Lampe PD, Hanash SM.

Cancer Prev Res (Phila). 2015 Nov;8(11):1112-9. doi: 10.1158/1940-6207.CAPR-15-0077. Epub 2015 Sep 4.

21.

Nano-cerium vanadate: a novel inorganic ion exchanger for removal of americium and uranium from simulated aqueous nuclear waste.

Banerjee C, Dudwadkar N, Tripathi SC, Gandhi PM, Grover V, Kaushik CP, Tyagi AK.

J Hazard Mater. 2014 Sep 15;280:63-70. doi: 10.1016/j.jhazmat.2014.07.026. Epub 2014 Jul 22.

PMID:
25128895
22.

Removal of americium from aqueous nitrate solutions by sorption onto PC88A-impregnated macroporous polymeric beads.

Pathak SK, Tripathi SC, Singh KK, Mahtele AK, Kumar M, Gandhi PM.

J Hazard Mater. 2014 Aug 15;278:464-73. doi: 10.1016/j.jhazmat.2014.06.022. Epub 2014 Jun 21.

PMID:
24997262
23.

Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing.

Pandey A, Tripathi SC, Mahata S, Vishnoi K, Shukla S, Misra SP, Misra V, Hedau S, Mehrotra R, Dwivedi M, Bharti AC.

World J Gastroenterol. 2014 Jun 14;20(22):6860-8. doi: 10.3748/wjg.v20.i22.6860.

24.

Uptake of hazardous radionuclides within layered chalcogenide for environmental protection.

Sengupta P, Dudwadkar NL, Vishwanadh B, Pulhani V, Rao R, Tripathi SC, Dey GK.

J Hazard Mater. 2014 Feb 15;266:94-101. doi: 10.1016/j.jhazmat.2013.12.010. Epub 2013 Dec 14.

PMID:
24384375
25.

Tributyl phosphate biodegradation to butanol and phosphate and utilization by a novel bacterial isolate, Sphingobium sp. strain RSMS.

Rangu SS, Muralidharan B, Tripathi SC, Apte SK.

Appl Microbiol Biotechnol. 2014 Mar;98(5):2289-96. doi: 10.1007/s00253-013-5158-5. Epub 2013 Aug 21.

PMID:
23963271
26.

Supported liquid membrane transport studies on Am(III), Pu(IV), U(VI) and Sr(II) using irradiated TODGA.

Panja S, Mohapatra PK, Tripathi SC, Gandhi PM, Janardan P.

J Hazard Mater. 2012 Oct 30;237-238:339-46. doi: 10.1016/j.jhazmat.2012.08.055. Epub 2012 Aug 31.

PMID:
22975254
27.

Facilitated transport of Pd(II) through a supported liquid membrane (SLM) containing N,N,N',N'-tetra-(2-ethylhexyl) thiodiglycolamide T(2EH)TDGA: a novel carrier.

Ruhela R, Panja S, Sharma JN, Tomar BS, Tripathi SC, Hubli RC, Suri AK.

J Hazard Mater. 2012 Aug 30;229-230:66-71. doi: 10.1016/j.jhazmat.2012.05.064. Epub 2012 May 27.

PMID:
22704775
28.

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW.

Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14.

29.

Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.

Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, Dattagupta S, Sharma MC, Ralhan R, Siu KW.

PLoS One. 2011 May 5;6(5):e19213. doi: 10.1371/journal.pone.0019213.

30.

Facilitated transport of uranium(VI) across supported liquid membranes containing T2EHDGA as the carrier extractant.

Panja S, Mohapatra PK, Tripathi SC, Manchanda VK.

J Hazard Mater. 2011 Apr 15;188(1-3):281-7. doi: 10.1016/j.jhazmat.2011.01.109. Epub 2011 Feb 2.

PMID:
21333441
31.

Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.

Ralhan R, He HC, So AK, Tripathi SC, Kumar M, Hasan MR, Kaur J, Kashat L, MacMillan C, Chauhan SS, Freeman JL, Walfish PG.

PLoS One. 2010 Nov 30;5(11):e14130. doi: 10.1371/journal.pone.0014130.

32.

Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma.

Kausar T, Sharma R, Hasan MR, Tripathi SC, Saraya A, Chattopadhyay TK, Gupta SD, Ralhan R.

Cancer Invest. 2011 Jan;29(1):42-8. doi: 10.3109/07357907.2010.512597. Epub 2010 Sep 27.

PMID:
20874003
33.

Nuclear S100A7 is associated with poor prognosis in head and neck cancer.

Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW.

PLoS One. 2010 Aug 3;5(8):e11939. doi: 10.1371/journal.pone.0011939.

34.

Removal of 241Am from aqueous nitrate solutions by liquid surfactant membrane containing 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester as ion carrier.

Kedari CS, Pandit SS, Parikh KJ, Tripathi SC.

Chemosphere. 2010 Jun;80(4):433-7. doi: 10.1016/j.chemosphere.2010.04.056. Epub 2010 May 21.

PMID:
20488505
35.

Promoter hypermethylation in Indian primary oral squamous cell carcinoma.

Kaur J, Demokan S, Tripathi SC, Macha MA, Begum S, Califano JA, Ralhan R.

Int J Cancer. 2010 Nov 15;127(10):2367-73. doi: 10.1002/ijc.25377.

36.

Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.

Matta A, Tripathi SC, DeSouza LV, Grigull J, Kaur J, Chauhan SS, Srivastava A, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Michael Siu KW.

Int J Cancer. 2009 Sep 15;125(6):1398-406. doi: 10.1002/ijc.24517.

37.

iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.

Ralhan R, Desouza LV, Matta A, Tripathi SC, Ghanny S, Dattagupta S, Thakar A, Chauhan SS, Siu KW.

J Proteome Res. 2009 Jan;8(1):300-9. doi: 10.1021/pr800501j.

PMID:
19072117
38.

Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Ralhan R, Desouza LV, Matta A, Tripathi SC, Ghanny S, Datta Gupta S, Bahadur S, Siu KW.

Mol Cell Proteomics. 2008 Jun;7(6):1162-73. doi: 10.1074/mcp.M700500-MCP200. Epub 2008 Mar 13.

39.

EPR investigations on radiation induced chemical transformations in Pd(ClO4)2/i-PrOH/HClO4 system from 77 to 300 K.

Tripathi SC, Kadam RM, Kumar M, Mittal JP, Mishra SP.

Spectrochim Acta A Mol Biomol Spectrosc. 2005 Dec;62(4-5):1107-13. Epub 2005 Jun 13.

PMID:
15955724
40.

A comparison of anion-exchange and steric-exclusion HPLC assays of mouse plasma lipoproteins.

Neyer J, Espinoza C, Luppen L, Dohety TM, Tripathi SC, Uzui H, Tripathi PV, Lee G, Shah PK, Rajavashisth TB.

J Lipid Res. 2005 Aug;46(8):1786-95. Epub 2005 Mar 16.

41.

Regulatory considerations for preclinical development of anticancer drugs.

DeGeorge JJ, Ahn CH, Andrews PA, Brower ME, Giorgio DW, Goheer MA, Lee-Ham DY, McGuinn WD, Schmidt W, Sun CJ, Tripathi SC.

Cancer Chemother Pharmacol. 1998;41(3):173-85. Review.

PMID:
9443633
42.

Hepatoprotective activity of Boerhaavia diffusa L. roots--a popular Indian ethnomedicine.

Rawat AK, Mehrotra S, Tripathi SC, Shome U.

J Ethnopharmacol. 1997 Mar;56(1):61-6.

PMID:
9147255
43.

Arachidonic acid metabolism and cell proliferation in rat mammary carcinoma cells treated with indomethacin.

Tripathi SC, Vosseller KA, McCormick DL.

Biochim Biophys Acta. 1996 May 24;1316(1):5-7.

44.

Milk fever in swine--a case report.

Tripathi SC.

Trop Anim Health Prod. 1994 May;26(2):118. No abstract available.

PMID:
7941027
45.

Mechanical stress mechanisms and the cell. An endothelial paradigm.

Davies PF, Tripathi SC.

Circ Res. 1993 Feb;72(2):239-45. Review.

PMID:
8418981
46.

Characterization of GP110, a neutrophil surface protein.

Tripathi SC, Van Dyke TE.

Infect Immun. 1992 Jul;60(7):3015-6.

47.

Recent developments in vertebrate cell culture technology.

Parulekar SJ, Hassell T, Tripathi SC.

Int Rev Cytol. 1992;142:145-211. Review. No abstract available.

PMID:
1487395
48.

Antihepatotoxic properties of picroliv: an active fraction from rhizomes of Picrorhiza kurrooa.

Ansari RA, Tripathi SC, Patnaik GK, Dhawan BN.

J Ethnopharmacol. 1991 Aug;34(1):61-8.

PMID:
1753788
49.

A new method for estimating population doubling time of vertebrate cells.

Tripathi SC, Donaghey CE.

J Biotechnol. 1991 Jun;19(1):111-5.

PMID:
1367177
50.

Locomotory behavior of fibroblasts in "sail-sheets".

Tripathi SC.

In Vitro Cell Dev Biol. 1989 Nov;25(11):980-6.

PMID:
2592304

Supplemental Content

Loading ...
Support Center